Citation Impact
Citing Papers
Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations
2013
Induction of PD-L1 Expression by the EML4–ALK Oncoprotein and Downstream Signaling Pathways in Non–Small Cell Lung Cancer
2015
The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
2012
Evolution of the Cancer Stem Cell Model
2014 Standout
An outline of necrosome triggers
2016
Tryptophan Catabolites from Microbiota Engage Aryl Hydrocarbon Receptor and Balance Mucosal Reactivity via Interleukin-22
2013 Standout
Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
2016
Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells
2019
Cancer therapy in the necroptosis era
2016
Cancer treatment and survivorship statistics, 2022
2022 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology
2006 Standout
The molecular hallmarks of epigenetic control
2016 Standout
The macroscopic structure of RADA16 peptide hydrogel stimulates monocyte/macrophage differentiation in HL60 cells via cholesterol synthesis
2013
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
2016 Standout
Synovial Tissue Inflammation Mediated by Autoimmune T Cells
2019 StandoutNobel
Neutrophilic leukocytosis in advanced stage polycythemia vera: hematopathologic features and prognostic implications
2015
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
The past and future of CD33 as therapeutic target in acute myeloid leukemia
2014
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Head and neck cancer
2008 Standout
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Host Indoleamine 2,3-Dioxygenase: Contribution to Systemic Acquired Tumor Tolerance
2012
Microenvironment Tumor Metabolic Interactions Highlighted by qMSI: Application to the Tryptophan-Kynurenine Pathway in Immuno-Oncology
2017
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Immunogenic cell death in cancer and infectious disease
2016 Standout
Possible roles of excess tryptophan metabolites in cancer
2010
Cancer stem cells revisited
2017 Standout
The molecular machinery of regulated cell death
2019 Standout
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Scleroderma
2009 Standout
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
Prevalence of Malnutrition and Current Use of Nutrition Support in Patients With Cancer
2014
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Cancer-associated cachexia
2018 Standout
Strategies to Inhibit Myc and Their Clinical Applicability
2017
Targeting apoptosis in cancer therapy
2020 Standout
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
2017
Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
2016
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma
2014
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms
2015
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
2016 Standout
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Role of the gut microbiota in nutrition and health
2018 Standout
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
2015 StandoutNobel
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Driver mutations of cancer epigenomes
2014
Targeting the indoleamine 2,3-dioxygenase pathway in cancer
2015
A.S.P.E.N. Clinical Guidelines: Nutrition Support Therapy During Adult Anticancer Treatment and in Hematopoietic Cell Transplantation
2009
Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD
2008
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
Defining trained immunity and its role in health and disease
2020 Standout
Trial watch: IDO inhibitors in cancer therapy
2014
Connections between TET proteins and aberrant DNA modification in cancer
2014
Comprehensive Integration of Single-Cell Data
2019 Standout
BRD4 inhibitors block telomere elongation
2017 Nobel
Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences
2018
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
2017 StandoutNature
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of the ALFA-0701 trial
2014
Combining Targeted Therapy With Immunotherapy in BRAF-Mutant Melanoma: Promise and Challenges
2014
Molecular Pathways: Next-Generation Immunotherapy—Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
2012
The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology
2008
Necroptosis: Mechanisms and Relevance to Disease
2016
Role of indoleamine 2,3-dioxygenase in health and disease
2015
BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure
2017
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Acute Myeloid Leukemia
2015 Standout
Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a M ayo C linic‐F rench C onsortium S tudy
2014
Hypomethylating agent combination strategies in myelodysplastic syndromes: hopes and shortcomings
2016
BET Proteins as Targets for Anticancer Treatment
2017
Loss of TET proteins in regulatory T cells promotes abnormal proliferation, Foxp3 destabilization and IL-17 expression
2019 StandoutNobel
The role of B7 family molecules in hematologic malignancy
2012
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
2014
Cancer treatment and survivorship statistics, 2016
2016 Standout
Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia
2016
How I treat refractory and early relapsed acute myeloid leukemia
2015
Chemotherapy Options for Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
2006
Cancer treatment and survivorship statistics, 2019
2019 Standout
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
2014
Bromodomain and Extra-Terminal Motif Inhibitors: a Review of Preclinical and Clinical Advances in Cancer Therapy
2019
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia
2014
Blocking IDO activity to enhance anti-tumor immunity
2011
Impact of interferon-γ on hematopoiesis
2014
Leukemia cell–targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity
2013
Works of Céline Berthon being referenced
In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors
2010
RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage
2014
Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50–70‐year old: A phase 1/2 study of the acute leukemia French association
2011
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
2016
Metabolites of tryptophan catabolism are elevated in sera of patients with myelodysplastic syndromes and inhibit hematopoietic progenitor amplification
2013
Expression of CD34 in hematopoietic cancer cell lines reflects tightly regulated stem/progenitor‐like state
2011
Allogeneic stem-cell transplantation with fludarabine and 2-Gy TBI-based conditioning regimen for chronic hematological malignancy: A study of 25 consecutive patients and a literature review
2007
Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?
2011
Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association
2012
Prognosis of hypercalcemia in aerodigestive tract cancers: Study of 136 recent cases
2005
Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients’ sera by HPLC and is inducible by IFN-γ
2008
A Phase 1 Study of the BET-Bromodomain Inhibitor OTX015 in Patients with Advanced Acute Leukemia
2014
Clonal architecture of chronic myelomonocytic leukemias
2013
Enteral Feeding and Early Outcomes of Patients Undergoing Allogeneic Stem Cell Transplantation Following Myeloablative Conditioning
2006